|
ZNF275 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.08000003279574E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.93650000041212E-07 |
| Normal-vs-Stage2 |
1.479710E-02 |
| Normal-vs-Stage3 |
2.40749997715284E-09 |
| Normal-vs-Stage4 |
9.67790000000468E-05 |
| Stage1-vs-Stage2 |
9.926400E-01 |
| Stage1-vs-Stage3 |
5.201600E-02 |
| Stage1-vs-Stage4 |
3.841200E-01 |
| Stage2-vs-Stage3 |
3.781400E-01 |
| Stage2-vs-Stage4 |
5.738400E-01 |
| Stage3-vs-Stage4 |
7.435000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.05590000579292E-09 |
| Normal-vs-AfricanAmerican |
1.647750E-02 |
| Normal-vs-Asian |
2.362400E-01 |
| Caucasian-vs-AfricanAmerican |
8.174800E-01 |
| Caucasian-vs-Asian |
4.421200E-01 |
| AfricanAmerican-vs-Asian |
6.958600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.86900006161306E-10 |
| Normal-vs-Female |
2.09019999999338E-05 |
| Male-vs-Female |
2.395200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.294800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.31549999999414E-05 |
| Normal-vs-Age(61-80Yrs) |
5.09730035958E-10 |
| Normal-vs-Age(81-100Yrs) |
1.79500000418997E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.240000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.932400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.067800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.471700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.039200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.867900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.479700E-02 |
| Normal-vs-Grade 2 |
3.95200000000706E-05 |
| Normal-vs-Grade 3 |
4.39499991955472E-10 |
| Normal-vs-Grade 4 |
6.7447999962944E-08 |
| Grade 1-vs-Grade 2 |
7.528600E-01 |
| Grade 1-vs-Grade 3 |
7.759700E-02 |
| Grade 1-vs-Grade 4 |
6.196100E-02 |
| Grade 2-vs-Grade 3 |
2.385800E-02 |
| Grade 2-vs-Grade 4 |
4.849700E-02 |
| Grade 3-vs-Grade 4 |
7.067200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.15960005434113E-09 |
| Normal-vs-ccB subtype |
2.777900E-03 |
| ccA subtype-vs-ccB subtype |
5.669900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.83549999999144E-06 |
| Normal-vs-N1 |
9.195400E-04 |
| N0-vs-N1 |
5.696600E-01 |
|
|
